RXi Pharmaceuticals Corp (NASDAQ:RXII) President and Ceo Geert Cauwenbergh has purchased 2,000 shares of common stock, $0.0001 par value, at an average price of $ 2.98 Per share. Following this transaction, Mr. Cauwenbergh owns 26,100 shares at the company. This is not the first acquisition Mr. Cauwenbergh has done over the course of this year. He acquired, during the last reported quarter, 3,000 shares, apart from the 2,000 recently reported, at prices ranging from $ 2.91 to $ 3.05 per share. This insider is the only one to have procured this stock during 2014.
Moreover, sales haven’t been frequent at RXi Pharmaceuticals Corp (NASDAQ:RXII). In fact, last insider sell was made by Large Shareholder Galena Biopharma, Inc., selling 912,500 shares, at a price of $0.19 per share, during Q2 2013.
This Biotechnology & Medical Research Company, with a Market Cap of $41.10 Million, hasn’t witnessed any important hedge fund investment over the past years.
Disclosure: none.
Suggested Reading:
The 15 Most Common Phobias in America that Induce Fits of Panic
The 10 Most Hated Television Characters of All Time
